HRT Financial’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-140,206
Closed -$16K 3630
2024
Q4
$16K Buy
+140,206
New +$17.7K ﹤0.01% 2242
2024
Q2
Sell
-39,316
Closed -$5K 3390
2024
Q1
$5K Buy
39,316
+29,209
+289% +$4.09K ﹤0.01% 2113
2023
Q4
$2K Sell
10,107
-33,347
-77% -$5.86K ﹤0.01% 2190
2023
Q3
$7K Buy
43,454
+1,510
+4% +$293 ﹤0.01% 2163
2023
Q2
$8K Sell
41,944
-24,599
-37% -$4.99K ﹤0.01% 2198
2023
Q1
$14K Buy
66,543
+13,494
+25% +$3.31K ﹤0.01% 2226
2022
Q4
$8K Buy
53,049
+33,923
+177% +$6.95K ﹤0.01% 2247
2022
Q3
$4K Buy
+19,126
New +$5.06K ﹤0.01% 2626
2022
Q2
Sell
-273,588
Closed -$92K 4126
2022
Q1
$92K Buy
+273,588
New +$89.5K ﹤0.01% 2680
2021
Q4
Sell
-399,494
Closed -$209K 4541
2021
Q3
$209K Buy
+399,494
New +$236K ﹤0.01% 2659
2021
Q2
Sell
-2,279,287
Closed -$3.6M 3874
2021
Q1
$3.6M Buy
+2,279,287
New +$3.72M 0.04% 369

Other funds holding ZOM

HRT Financial's ZOM Position: Q1 2025 in Review

HRT Financial sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 140,206 shares — an estimated $16K sold.

HRT Financial first reported a position in ZOM in Q1 2021 and held it in 11 quarters. The position peaked at $3.6M in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • HRT Financial reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 140,206 Zomedica Corp. shares in Q1 2025, an estimated $16K.
  • HRT Financial first reported a position in Zomedica Corp. in Q1 2021 and held it in 11 quarters.
  • HRT Financial's Zomedica Corp. position peaked at $3.6M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.